WAU
GILD icon

Wellington-Altus USA’s Gilead Sciences GILD Stock Holding History

Wellington-Altus USA’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.2K Hold
468
– – 0.05% 264
2026
Q1 		$59.1K Buy
468
+400
+588% +$56K 0.03% 311
2025
Q4 		$8.35K Buy
+68
New +$8.26K 0.01% 590

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington-Altus USA's GILD Position: Q2 2026 in Review

Wellington-Altus USA held its Gilead Sciences (GILD) position steady in Q2 2026 at 468 shares worth $65.2K. The position accounts for 0.05% of the portfolio, ranked #264.

Wellington-Altus USA first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,287 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wellington-Altus USA held 468 shares of Gilead Sciences worth $65.2K as of Q2 2026.
  • Wellington-Altus USA left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.05% of Wellington-Altus USA's portfolio in Q2 2026, its #264 holding.
  • Wellington-Altus USA first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,287 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wellington-Altus USA's 13F filing for Q2 2026, filed 17 Sep 2026.